A

Aquestive Therapeutics
D

AQST

2.35500
USD
0.06
(2.61%)
مغلق
حجم التداول
42,440
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
233,917,270
أصول ذات صلة
A
ACRE
-0.06000
(-1.31%)
4.51000 USD
A
ADMA
0.260
(1.29%)
20.420 USD
ALNY
ALNY
0.47
(0.16%)
289.82 USD
A
ANIP
0.557
(0.97%)
57.800 USD
A
ARWR
-0.250
(-1.62%)
15.140 USD
A
AXSM
0.810
(0.78%)
104.990 USD
B
BCRX
0.215
(2.07%)
10.590 USD
B
BHC
-0.05000
(-1.11%)
4.45000 USD
C
CRBP
-0.15000
(-1.99%)
7.40000 USD
المزيد
الأخبار المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.